Skip to main content
Industry News
Study: SSRI treatment may raise T2D risk in children
9/16/2020

A study in JAMA Psychiatry involving more than one million children found that those who initiated a treatment of selective serotonin reuptake inhibitors had a 13% higher risk of developing type 2 diabetes, compared with those who did not initiate SSRI treatment. "This potential risk, which is much lower in magnitude than the other known risk factors for [type 2 diabetes], should be weighed against the known benefits and risks of SSRI treatment to help inform treatment decision making in the pediatric population," the researchers wrote.

Full Story: